Literature in Oncology: Gynaecological Tumours
Cho O, Chun M, Oh YT, Kim MH, Park HJ, Heo JS, Noh OK.
Can initial diagnostic PET-CT aid to localize tumor bed in breast cancer radiotherapy: feasibility study using deformable image registration.
Radiat Oncol. 2013 Jul 3;8:163.
Klumpp B, Aschoff P, Schwenzer N, Koenigsrainer I, Beckert S, Claussen CD, Miller S, Koenigsrainer A, Pfannenberg C.
Correlation of preoperative magnetic resonance imaging of peritoneal carcinomatosis and clinical outcome after peritonectomy and HIPEC after 3 years of follow-up: preliminary results.
Cancer Imaging. 2013 Dec 30;13(4):540-7.
Kitajima K, Ueno Y, Suzuki K, Kita M, Ebina Y, Yamada H, Senda M, Maeda T, Sugimura K.
Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT scans for diagnosing ovarian cancer recurrence.
Eur J Radiol. 2012 Nov;81(11):3557-62.
Choi BB, Kim SH, Kang BJ, Lee JH, Song BJ, Jeong SH, Yim HW.
Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma.
World J Surg Oncol. 2012 Jun 28;10:126.
Bilici A, Ustaalioglu BB, Seker M, Canpolat N, Tekinsoy B, Salepci T, Gumus M.
Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?
Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1259-69.
Groves AM, Wishart GC, Shastry M, Moyle P, Iddles S, Britton P, Gaskarth M, Warren RM, Ell PJ, Miles KA.
Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT.
Eur J Nucl Med Mol Imaging. 2009 Mar;36(3):416-21.
Kitajima K, Murakami K, Yamasaki E, Domeki Y, Kaji Y, Morita S, Suganuma N, Sugimura K.
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT.
Eur J Nucl Med Mol Imaging. 2009 Mar;36(3):362-72.
Kitajima K, Murakami K, Yamasaki E, Domeki Y, Kaji Y, Fukasawa I, Inaba N, Suganuma N, Sugimura K.
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.
Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1439-48.
Mangili G, Picchio M, Sironi S, Viganò R, Rabaiotti E, Bornaghi D, Bettinardi V, Crivellaro C, Messa C, Fazio F.
Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer.
Eur J Nucl Med Mol Imaging. 2007 May;34(5):658-66.